Unknown

Dataset Information

Effect of human milk-based fortification in extremely preterm infants fed exclusively with breast milk: a randomised controlled trial.


ABSTRACT:

Background

Mortality and severe morbidity remain high in extremely preterm infants. Human milk-based nutrient fortifiers may prevent serious complications and death. We aimed to investigate whether supplementation with human milk-based fortifier (HMBF), as compared to bovine milk-based fortifier (BMBF), reduced the incidence of the composite outcome of necrotising enterocolitis (NEC), sepsis, and mortality in extremely preterm infants exclusively fed human milk.

Methods

In this multicentre, randomised controlled trial at 24 neonatal units in Sweden, extremely preterm infants born between gestational week 22 + 0 and 27 + 6 fed exclusively human breast milk (mother's own and/or donor milk), were randomly assigned (1:1) to receive targeted fortification with either HMBF or BMBF

SUBMITTER: Jensen GB 

PROVIDER: S-EPMC10965410 | biostudies-literature | 2024 Feb

REPOSITORIES: biostudies-literature